FTC identifies CBD retailers warned about health claims

A federal consumer protection agency has identified four CBD manufacturers it flagged for unfair and deceptive advertising.

The U.S. Federal Trade Commission (FTC) announced warning letters were sent last month to four companies selling hemp-derived CBD products.

At the time, the agency did not name the companies. A public records request posted this week made those warnings public.

The companies were:

• 4Bush Holdings, owner of magicgreenoildrops.com and firstclassherbalistcbd.com
• NuLife CBD Oils
• Ocanna
• Relievus

The companies were warned to remove health claims from their websites and marketing materials, including customer testimonials. The companies’ responses were not made public.

Like the U.S. Food and Drug Administration (FDA), the FTC can fine companies that make unproven medical claims, though enforcement actions beyond warning letters are rare.

Included in the newly released CBD warnings was a notice that a CBD manufacturer that includes a nutrition fact panel on a tincture “suggests that it is a food” and not a dietary supplement, violating an FDA rule that “prohibits the introduction into interstate commerce of any food to which CBD has been added.”

To read the full FTC warnings, click here.